Skip to main content
Michael Presti, MD, Neurology, Gainesville, FL

Michael Franz Presti MD PhD

Pain Medicine, Sleep Medicine


CEO, SafeRX Pharmaceuticals Inc.

Join to View Full Profile
  • 1600 SW Archer RdGainesville, FL 32610

  • Phone+1 352-273-8737

  • Fax+1 352-273-9154

Dr. Presti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Sleep Medicine, 2012 - 2013
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 2009 - 2012
  • University of Maryland Medical Center Midtown Campus
    University of Maryland Medical Center Midtown CampusInternship, Transitional Year, 2008 - 2009
  • University of Florida College of Medicine
    University of Florida College of MedicineClass of 2008

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - 2026
  • MA State Medical License
    MA State Medical License 2022 - 2024
  • CA State Medical License
    CA State Medical License 2019 - 2023
  • NY State Medical License
    NY State Medical License 2021 - 2023
  • OR State Medical License
    OR State Medical License 2014 - 2021
  • MN State Medical License
    MN State Medical License 2009 - 2014
  • Neurology
    American Board of Psychiatry and Neurology Neurology
  • Sleep Medicine
    American Board of Psychiatry and Neurology Sleep Medicine

Publications & Presentations

PubMed

Journal Articles

  • Degeneration of brainstem respiratory neurons in dementia with Lewy bodies  
    Presti MF; Schmeichel MA; Low PA; Parisi JE; Benarroch EE, Sleep, 2/2014

Authored Content

  • Fix Roof, Not Tarp in Battle Against Opioid CrisisMay 2021

Press Mentions

  • SafeRX Pharmaceuticals to Exhibit Alcohol-Resistant Opioid Platform at 2021 FSIPP/FSPMR Annual Conference
    SafeRX Pharmaceuticals to Exhibit Alcohol-Resistant Opioid Platform at 2021 FSIPP/FSPMR Annual ConferenceJuly 26th, 2021

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: